Beyond XX and XY, Understanding Sex Differences in Leukemia
Medical Sciences · 11.01.2026 · 14 (1) · 38
DOI: 10.3390/medsci14010038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 11.01.2026. Verfasst von Mai Mostafa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, 38106 Braunschweig, Germany. Hauptthemen laut MEDLINE: Leukemia, Sex Characteristics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The major subtypes of leukemia show sex differences. This review summarizes current knowledge and identifies gaps regarding sex differences across acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and chronic lymphoblastic leukemia in epidemiology, mortality and survival rates, risk factors, and epigenetic, metabolomic, and sex-specific patterns. Males have higher incidence and mortality rates of leukemia compared to females, emphasizing the importance of biological sex. Underreporting of sex differences in leukemia is highlighted, suggesting that sex is often overlooked as a research variable. A significant clinical observation is that women demonstrate higher overall survival rates but experience more severe treatment-related toxicity. Clinically, women tend to survive longer but experience more severe side effects. In contrast, a significant clinical observation in pediatric leukemia contradicts this enigma, suggesting that sex differences may be less pronounced during childhood. These differences play a significant role in how the disease develops. This review presents a sex-based perspective for hematological and biochemical patterns, genetic risk factors, environmental, lifestyle, and parental risk factors, epigenetics and metabolites. Furthermore, males and females might have different responses to the same toxic, environmental, and hormonal exposures. Trying to understand these disparities better based on molecular mechanisms is considered an approach for precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, 38106 Braunschweig, Germany.
- Pediatric Oncology Department, Children's Cancer Hospital Egypt (CCHE-57357), Cairo 11311, Egypt.
- Biochemistry Department, German University in Cairo, Cairo 11835, Egypt.
- Department of Pharmaceutical Chemistry, German University in Cairo, Cairo 11835, Egypt.
ORCID-Profile: Mai Mostafa, Mohamed Z Gad, Rasha Hanafi, Sami El Deeb
Zitieren
APA
Mostafa, M., Elhaddad, A., Gad, M. Z., Hanafi, R., Rashad, H., & El Deeb, S. (2026). Beyond XX and XY, Understanding Sex Differences in Leukemia. Medical Sciences, 14(1), 38. https://doi.org/10.3390/medsci14010038
Vancouver
Mostafa M, Elhaddad A, Gad MZ, Hanafi R, Rashad H, El Deeb S. Beyond XX and XY, Understanding Sex Differences in Leukemia. Medical Sciences. 2026;14(1):38. doi:10.3390/medsci14010038
BibTeX
@article{Mostafa2026,
author = {Mostafa, Mai and Elhaddad, Alaa and Gad, Mohamed Z and Hanafi, Rasha and Rashad, Hanaa and El Deeb, Sami},
title = {Beyond XX and XY, Understanding Sex Differences in Leukemia},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {1},
pages = {38},
doi = {10.3390/medsci14010038}
}
EUVIMED